The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer

References

• Visvanathan K, Hurley P, Bantug E, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013;31:2942–62
   PubMed Web of Science ®Google Scholar
• Hiatt RA, Porco TC, Liu F, et al. A multi-level model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2014 July 13. Epub ahead of print
   PubMedGoogle Scholar
• Vogel VG, Costantino JP, Wickerham DL, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: Preventing breast cancer. Cancer Prev Res 2010;3:696–706
   PubMed Web of Science ®Google Scholar
• Vogel VG. The NSABP Study of Tamoxifen and Raloxifene (STAR) trial. Expert Rev Anticancer Ther 2009;9:51–60
   PubMed Web of Science ®Google Scholar
• Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes. JAMA 2007;295:2727–41
   Web of Science ®Google Scholar
• Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 2008;114:71–83
   PubMedGoogle Scholar
• Berrino F, Villarini A, Traina A, et al. Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 2014; 147:159–65
   PubMed Web of Science ®Google Scholar
• Vrieling A, Buck K, Kaaks R, Chang-Claude J. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat 2010;123:641–9
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 2014;311:806–14
   PubMed Web of Science ®Google Scholar
• Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res 2013;19:6074–83
   PubMed Web of Science ®Google Scholar
• Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565–74
   PubMed Web of Science ®Google Scholar
• Elkhadrawy TM, Ahsan H, Neugut AI. Serum cholesterol and the risk of ductal carcinoma in situ: a case-control study. Eur J Cancer Prev 1998;7:393–6
   PubMed Web of Science ®Google Scholar
• Potluri R, Lavu D, Uppal H, Chandran S. Hyperlipidaemia as a risk factor for breast cancer? Cardiovascular Res Suppl 2014; 103:S102–43
   Google Scholar
• His M, Zelek L, Deschasaux M, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol 2014;29:119–32
   PubMed Web of Science ®Google Scholar
• Boyd NF, McGuire V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 1990;82:460–8
   PubMed Web of Science ®Google Scholar
• Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat 2012;135:261–9
   PubMed Web of Science ®Google Scholar
• Danilo C, Frank PG. Cholesterol and breast cancer development. Curr Opin Pharmacol 2012;12:677–82
   PubMed Web of Science ®Google Scholar
• Llaverias G, Danilo C, Mercier I, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol 2011; 178:402–12
   PubMed Web of Science ®Google Scholar
• Laisupasin P, Thompat W, Sukarayodhin S, Sornprom A, Sudjaroen Y. Comparison of serum lipid profiles between normal controls and breast cancer patients. J Lab Physicians 2013;5:38–41
   PubMedGoogle Scholar
• Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer. Ann Oncol 2012;23:491–500
   PubMed Web of Science ®Google Scholar
• Ronco AL, De Stefani E, Stoll M. Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer. Breast 2010;19:322–32
   PubMed Web of Science ®Google Scholar
• Ha M, Sung J, Song YM. Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 2009;20:1055–60
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 2011;29:1592–8
   PubMed Web of Science ®Google Scholar
• Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: A Danish nationwide prospective cohort study. J Natl Cancer Inst 2011;103:1461–8
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med 2012;367:1792–802
   PubMed Web of Science ®Google Scholar
• Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 2008;109:573–9
   PubMed Web of Science ®Google Scholar
• Llaverias G, Danilo C, Mercier I, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol 2011;178:402–12
   PubMed Web of Science ®Google Scholar
• Brewer TM, Masuda H, Liu DD, et al. Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer 2013;109:318–24
   PubMed Web of Science ®Google Scholar
• Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 2013;342:1094–8
   PubMed Web of Science ®Google Scholar
• Sullivan PM, Mezdour H, Aratani Y, et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 1997;272:17972–80
   PubMed Web of Science ®Google Scholar
• Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 1995;25: 667–73
   PubMed Web of Science ®Google Scholar
• Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 2007;104:6511–18
   PubMed Web of Science ®Google Scholar
• Szanto A, Benko S, Szatmari I, et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol Cell Biol 2004;24:8154–66
   PubMed Web of Science ®Google Scholar
• Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009;325:100–4
   PubMed Web of Science ®Google Scholar
• Zhang L, Reue K, Fong LG, Young SG, Tontonoz P. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis. Arterioscler Thromb Vasc Biol 2012;32:2541–6
   PubMed Web of Science ®Google Scholar
• Alikhani N, Ferguson RD, Novosyadlyy R, et al. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene 2013;32:961–7
   PubMed Web of Science ®Google Scholar
• DuSell CD, McDonnell DP. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. Trends Pharmacol Sci 2008;29:510–14
   PubMed Web of Science ®Google Scholar
• DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 2008;22:65–77
   PubMed Web of Science ®Google Scholar
• Collins NH, Lessey EC, DuSell CD, et al. Characterization of anti-estrogenic activity of the Chinese herb, Prunella vulgaris, using in vitro and in vivo models. Biol Reprod 2009;80:375–83
   PubMed Web of Science ®Google Scholar
• DuSell CD, Nelson ER, Wang X, et al. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 2010;151: 3675–85
   PubMed Web of Science ®Google Scholar
• Nelson ER, DuSell CD, Wang X, et al. The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. Endocrinology 2011;152:4691–705
   PubMed Web of Science ®Google Scholar
• Umetani M, Domoto H, Gormley A, et al. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator that inhibits the cardiovascular effects of estrogen. Nature Med 2007; 13:1185–92
   PubMed Web of Science ®Google Scholar
• Karuna R, Holleboom AG, Motazacker MM, et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis 2011;214:448–55
   PubMed Web of Science ®Google Scholar
• Pencheva N, Buss CG, Posada J, Merghoub T, Tavazoie SF. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation. Cell 2014;156: 986–1001
   PubMed Web of Science ®Google Scholar
• Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009;30:575–9
   PubMed Web of Science ®Google Scholar
• Zhang W, Jiang H, Zhang J, et al. Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway. Cancer Cell Int 2014;14:16
   PubMedGoogle Scholar
• Wu Q, Ishikawa T, Sirianni R, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep 2013;5:637–45
   PubMed Web of Science ®Google Scholar
• Bahl M, Ennis M, Tannock IF, et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat 2005;94:135–44
   PubMed Web of Science ®Google Scholar
• Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 2013; 24:2506–14
   PubMed Web of Science ®Google Scholar